Literature DB >> 34362963

Towards precision cardiometabolic prevention: results from a machine learning, semi-supervised clustering approach in the nationwide population-based ORISCAV-LUX 2 study.

Guy Fagherazzi1,2, Lu Zhang3, Gloria Aguayo4, Jessica Pastore4, Catherine Goetzinger4,5, Aurélie Fischer4, Laurent Malisoux4, Hanen Samouda4, Torsten Bohn4, Maria Ruiz-Castell4, Laetitia Huiart4,5.   

Abstract

Given the rapid increase in the incidence of cardiometabolic conditions, there is an urgent need for better approaches to prevent as many cases as possible and move from a one-size-fits-all approach to a precision cardiometabolic prevention strategy in the general population. We used data from ORISCAV-LUX 2, a nationwide, cross-sectional, population-based study. On the 1356 participants, we used a machine learning semi-supervised cluster method guided by body mass index (BMI) and glycated hemoglobin (HbA1c), and a set of 29 cardiometabolic variables, to identify subgroups of interest for cardiometabolic health. Cluster stability was assessed with the Jaccard similarity index. We have observed 4 clusters with a very high stability (ranging between 92 and 100%). Based on distinctive features that deviate from the overall population distribution, we have labeled Cluster 1 (N = 729, 53.76%) as "Healthy", Cluster 2 (N = 508, 37.46%) as "Family history-Overweight-High Cholesterol ", Cluster 3 (N = 91, 6.71%) as "Severe Obesity-Prediabetes-Inflammation" and Cluster 4 (N = 28, 2.06%) as "Diabetes-Hypertension-Poor CV Health". Our work provides an in-depth characterization and thus, a better understanding of cardiometabolic health in the general population. Our data suggest that such a clustering approach could now be used to define more targeted and tailored strategies for the prevention of cardiometabolic diseases at a population level. This study provides a first step towards precision cardiometabolic prevention and should be externally validated in other contexts.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34362963     DOI: 10.1038/s41598-021-95487-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  3 in total

Review 1.  Evidence for the Prevention of Type 2 Diabetes Mellitus.

Authors:  Jay H Shubrook; William Chen; Alegria Lim
Journal:  J Am Osteopath Assoc       Date:  2018-11-01

2.  Unravelling the Obesity Paradox Through Bariatric Surgery-Reply.

Authors:  Kyle H Sheetz; Seth A Waits
Journal:  JAMA Surg       Date:  2020-12-01       Impact factor: 14.766

3.  More Considerations on Both Model Assumptions and Results Interpretations-Evaluating Readmission.

Authors:  Chengan Du; Guohai Zhou; Shu-Xia Li
Journal:  JAMA Intern Med       Date:  2019-11-01       Impact factor: 21.873

  3 in total
  1 in total

1.  Analysing breast cancer survivors' acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool.

Authors:  Catherine Goetzinger; Caroline Alleaume; Anna Schritz; Bernard Vrijens; Marie Préau; Guy Fagherazzi; Laetitia Huiart
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.